187 related articles for article (PubMed ID: 26690425)
1. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.
Gezer U; Yörüker EE; Keskin M; Kulle CB; Dharuman Y; Holdenrieder S
Int J Mol Sci; 2015 Dec; 16(12):29654-62. PubMed ID: 26690425
[TBL] [Abstract][Full Text] [Related]
2. Relevance of histone marks H3K9me3 and H4K20me3 in cancer.
Leszinski G; Gezer U; Siegele B; Stoetzer O; Holdenrieder S
Anticancer Res; 2012 May; 32(5):2199-205. PubMed ID: 22593510
[TBL] [Abstract][Full Text] [Related]
3. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
Gezer U; Holdenrieder S
In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
[TBL] [Abstract][Full Text] [Related]
4. Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer.
Gezer U; Ustek D; Yörüker EE; Cakiris A; Abaci N; Leszinski G; Dalay N; Holdenrieder S
Tumour Biol; 2013 Feb; 34(1):329-36. PubMed ID: 23086575
[TBL] [Abstract][Full Text] [Related]
5. Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3.
Rasmussen L; Herzog M; Rømer E; Micallef J; Bulut O; Wilhelmsen M; Christensen IJ; Nielsen HJ
Scand J Clin Lab Invest; 2016 Oct; 76(6):448-53. PubMed ID: 27291394
[TBL] [Abstract][Full Text] [Related]
6. Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients.
Gezer U; Mert U; Ozgür E; Yörüker EE; Holdenrieder S; Dalay N
Oncol Lett; 2012 May; 3(5):1095-1098. PubMed ID: 22783398
[TBL] [Abstract][Full Text] [Related]
7. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
[TBL] [Abstract][Full Text] [Related]
9. A novel proteomics approach to epigenetic profiling of circulating nucleosomes.
Van den Ackerveken P; Lobbens A; Turatsinze JV; Solis-Mezarino V; Völker-Albert M; Imhof A; Herzog M
Sci Rep; 2021 Mar; 11(1):7256. PubMed ID: 33790358
[TBL] [Abstract][Full Text] [Related]
10. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
11. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma.
Deligezer U; Akisik EE; Erten N; Dalay N
Clin Chem; 2008 Jul; 54(7):1125-31. PubMed ID: 18487283
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
[TBL] [Abstract][Full Text] [Related]
14. A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours.
Reddy D; Khade B; Pandya R; Gupta S
Clin Epigenetics; 2017; 9():30. PubMed ID: 28360947
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer.
Lin WH; Xiao J; Ye ZY; Wei DL; Zhai XH; Xu RH; Zeng ZL; Luo HY
Clin Epigenetics; 2021 Dec; 13(1):232. PubMed ID: 34961566
[TBL] [Abstract][Full Text] [Related]
16. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
[TBL] [Abstract][Full Text] [Related]
17. Dynamic and stable histone H3 methylation patterns at the Arabidopsis FLC and AP1 loci.
Saleh A; Alvarez-Venegas R; Avramova Z
Gene; 2008 Oct; 423(1):43-7. PubMed ID: 18638531
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.
Tóth K; Barták BK; Tulassay Z; Molnár B
Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067
[TBL] [Abstract][Full Text] [Related]
19. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer.
Rasmussen L; Christensen IJ; Herzog M; Micallef J; Nielsen HJ;
Oncotarget; 2018 Feb; 9(12):10247-10258. PubMed ID: 29535803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
